BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao Y, Gao Q, Pei L, Wang C, Jin L, Liao F. Current Status and Future Prospects of Biomarkers in the Diagnosis of Hepatocellular Carcinoma. Int J Biol Markers 2017;32:361-9. [DOI: 10.5301/ijbm.5000299] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Song X, Wu A, Ding Z, Liang S, Zhang C. Soluble Axl Is a Novel Diagnostic Biomarker of Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection. Cancer Res Treat 2020;52:789-97. [PMID: 32138467 DOI: 10.4143/crt.2019.749] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
2 Uzzaman A, Zhang X, Qiao Z, Zhan H, Sohail A, Wahid A, Shang Z, Guan X, Cao CX, Xiao H. Discovery of small extracellular vesicle proteins from human serum for liver cirrhosis and liver cancer. Biochimie 2020;177:132-41. [PMID: 32835735 DOI: 10.1016/j.biochi.2020.08.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Song S, Bai M, Li X, Gong S, Yang W, Lei C, Tian H, Si M, Hao X, Guo T. Early Predictive Value of Circulating Biomarkers for Sorafenib in Advanced Hepatocellular Carcinoma. Expert Rev Mol Diagn 2022. [PMID: 35234564 DOI: 10.1080/14737159.2022.2049248] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Cheng X, Huang Y, Li D, Yuan C, Li Z, Sun L, Jiang H, Ma J. A sensitive polymer dots fluorescent sensor for determination of α-L-fucosidase activity in human serum. Sensors and Actuators B: Chemical 2019;288:38-43. [DOI: 10.1016/j.snb.2019.02.076] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
5 Bai B, Lin Y, Hu J, Wang H, Li L, Zhao S, Zhang J, Meng W, Yue P, Bai Z, Li X. Peroxiredoxin2 downregulation enhances hepatocellular carcinoma proliferation and migration, and is associated with unfavorable prognosis in patients. Oncol Rep 2019;41:1539-48. [PMID: 30747220 DOI: 10.3892/or.2019.6977] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
6 Yan Y, He W, Chen Y, Li Q, Pan J, Yuan Y, Zeng W, Chen D, Xing W. Comprehensive Analysis to Identify the Encoded Gens of Sodium Channels as a Prognostic Biomarker in Hepatocellular Carcinoma. Front Genet 2022;12:802067. [DOI: 10.3389/fgene.2021.802067] [Reference Citation Analysis]
7 Zhao Y, Zhang L, Huo L, Pei L, Li Q, Li H, Jin L. Clinical significance of fucosylated GP73 in the differential diagnosis of hepatocellular carcinoma. Int J Biol Markers 2018;33:439-46. [PMID: 30238841 DOI: 10.1177/1724600818796646] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
8 Younis YS, Alegaily HS, Elagawy W, Semeya AA, Abo-Amer YE, El-Abgeegy M, Mostafa SM, Elsergany HF, Abd-Elsalam S. Serum Dickopff 1 as a Novel Biomarker in Hepatocellular Carcinoma Diagnosis and Follow Up After Ablative Therapy. Cancer Manag Res 2019;11:10555-62. [PMID: 31908527 DOI: 10.2147/CMAR.S218532] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Lee JE. How Should Biobanks Collect Biosamples for Clinical Application? A 20-year Biomarker-related Publication and Patent Trend Analysis. Osong Public Health Res Perspect 2018;9:105-11. [PMID: 30023154 DOI: 10.24171/j.phrp.2018.9.3.04] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]